Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath

NAActive, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2028

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

Urocross implant

Urocross implant inserted via delivery catheter

DIAGNOSTIC_TEST

Sham-control

Cystoscopy

Trial Locations (2)

24016

Virginia Tech-Carilion School of Medicine, Roanoke

60153

Loyola University Medical Center, Maywood

Sponsors
All Listed Sponsors
lead

Prodeon Medical, Inc

INDUSTRY

NCT05400980 - Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath | Biotech Hunter | Biotech Hunter